1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Shock in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (32.14) | 18.7374 |
1990's | 32 (57.14) | 18.2507 |
2000's | 3 (5.36) | 29.6817 |
2010's | 3 (5.36) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, XD; Guo, SJ; Hu, S; Hu, XH; Li, ZY; Liu, R; Wang, SM; Zhou, FQ | 1 |
Byrnes, AP; Smith, JS; Tian, J; Xu, Z | 1 |
Greiner, C; Hörnig, C; Pergola, C; Rossi, A; Sautebin, L; Schubert-Zsilavecz, M; Steinhilber, D; Werz, O; Zettl, H | 1 |
Takeda, K | 1 |
Jauchem, JR | 1 |
Apffel, D; Benveniste, J; Bessin, P; Bonnet, J; Desgroux, L; Pelas, I; Soulard, C | 1 |
Banba, N; Kasai, K; Nakamura, T; Sekiguchi, Y; Shimoda, S; Suzuki, Y; Takekoshi, K | 1 |
Szabó, C | 1 |
Fukuoka, T; Nakajima, Y; Nakano, H | 1 |
Caplan, MS; Hsueh, W; Huang, W; MacKendrick, W; Sun, XM; Tien, J | 1 |
Mahmood, F; Rahman, NN; Saeed, SA; Simjee, RU | 1 |
Chen, XS; Funk, CD; Johnson, EN; Sheller, JR | 1 |
Altavilla, D; Bussolino, F; Calapai, G; Campo, GM; Canale, P; Caputi, AP; Ioculano, M; Squadrito, F; Zingarelli, B | 1 |
Becker, K; Förster, W; Grupe, R; Lueddeckens, G | 1 |
Bree, M; Granger, DN; Hsueh, W; Huang, W; Qu, XW; Sun, XM | 1 |
Ayala, A; Chaudry, IH | 1 |
Abu-Zidan, FM; Lennquist, S; Walther, S | 1 |
Albert, DH; Carter, GW; Curtin, M; Davidsen, SK; Heyman, HR; Luo, G; Magoc, TJ; Morgan, DW; Sheppard, GS; Summers, JB; Tapang, P; Xu, L | 1 |
Gonzalez-Crussi, F; Hsueh, W; Huang, W; Qu, X; Rozenfeld, RA; Sun, X | 1 |
Abu-Zidan, FM | 1 |
Hsueh, W; Huang, W; Qu, XW; Rozenfeld, RA; Sun, X; Tan, XD | 1 |
Kistler, EB; Mitsuoka, H; Schmid-Schönbein, GW | 1 |
Amemiya, H; Fukuoka, T; Hayashi, R; Kenmochi, T; Nakajima, Y; Nakano, H; Suzuki, S | 1 |
Albert, DH; Carter, GW; Conway, RG; Guinn, DE; Heyman, HR; Magoc, T; Rhein, DA; Summers, JB | 1 |
Heuer, HO; Muacevic, G | 1 |
Altavilla, D; Bussolino, F; Campo, GM; Caputi, AP; Ioculano, M; Squadrito, F; Zingarelli, B | 1 |
Caplan, MS; Hsueh, W; Kelly, A; Zhang, C | 1 |
Asano, O; Harada, K; Katayama, K; Kimura, A; Kobayashi, S; Murakami, M; Nagaoka, J; Yamada, K; Yamatsu, I; Yoshimura, T | 1 |
Becker, K; Förster, W; Herfurth, ML; Schillinger, E | 1 |
Braquet, P; Filep, JG; Mózes, T | 1 |
Li, CL; Shen, YZ | 1 |
Feuerstein, G; Rabinovici, R; Yue, TL | 1 |
Braquet, P; Dmitrieva, AV; Sagach, VF | 1 |
Altavilla, D; Arena, A; Campo, GM; Caputi, AP; Santoro, G; Squadrito, F; Sturniolo, R | 1 |
Hsueh, W; Sun, XM | 1 |
Braquet, P; Etienne, A; Pannetier, MC; Soulard, C | 1 |
Amstutz, P; Guerin, B; Guidet, B; Maury, E; Offenstadt, G | 1 |
Fukuoka, T | 1 |
Fukuoka, T; Hisanaga, M; Kanehiro, H; Matsumoto, M; Nakajima, Y; Nakano, H; Segawa, M; Wada, T | 1 |
Lefer, AM | 2 |
Braquet, P; Hosford, D; Paubert-Braquet, M | 1 |
Fang, ZY; Yin, M | 1 |
Bahr, T; Becker, K; Förster, W; Grupe, R; Lueddeckens, G; Schaper, U; Scheuch, DW | 1 |
Braquet, P; Filep, J; Hermán, F; Mózes, T | 1 |
Braquet, P | 1 |
Bessin, P; Braquet, P; Paubert-Braquet, M; Vargaftig, BB | 1 |
Feuerstein, G; Hallenbeck, JM | 1 |
Feuerstein, G; Siren, AL | 1 |
Faden, AI; McIntosh, TK | 1 |
Blauhut, B; Doran, JE; Lundsgaard-Hansen, P | 1 |
Craft, DV; Lefer, AM; Lento, PH; Stahl, GL | 1 |
Bader, TJ; Myers, AK | 1 |
Bessin, P | 1 |
Fernandez-Gallardo, S; Inarrea, P; Nieto, ML; Sanchez Crespo, M | 1 |
Mikulaschek, AW; Toth, PD | 1 |
15 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Shock
Article | Year |
---|---|
[Role of increase in permeability and circulatory failure in the development of organ dysfunction in severe acute pancreatitis].
Topics: Acute Disease; Animals; Bradykinin; Capillary Permeability; Formycins; Histamine; Humans; Interleukin-1; Microcirculation; Neutrophil Infiltration; Pancreatitis; Platelet Activating Factor; Ribonucleotides; Severity of Illness Index; Shock; Thrombin; Thrombophilia; Tumor Necrosis Factor-alpha | 2004 |
The role of autacoids and the autonomic nervous system in cardiovascular responses to radio-frequency energy heating.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Autacoids; Autonomic Nervous System; Blood Pressure; Body Temperature; Heart Rate; Heat Stress Disorders; Histamine; Humans; Nitric Oxide; Platelet Activating Factor; Radio Waves; Receptors, Adrenergic; Shock | 2006 |
Alterations in nitric oxide production in various forms of circulatory shock.
Topics: Amino Acid Oxidoreductases; Animals; Enzyme Activation; Enzyme Induction; Glucocorticoids; Humans; Interleukin-1; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Shock; Tumor Necrosis Factor-alpha | 1995 |
Platelet activating factor and its role in trauma, shock, and sepsis.
Topics: Animals; Humans; Platelet Activating Factor; Sepsis; Shock; Wounds and Injuries | 1996 |
[The pathophysiological role of the platelet activating factor].
Topics: Animals; Asthma; Blood Pressure; Cardiac Output; Humans; Inflammation; Myocardial Contraction; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Shock | 1991 |
Platelet-activating factor in cardiovascular stress situations.
Topics: Animals; Blood Pressure; Cardiovascular Physiological Phenomena; Cardiovascular System; Humans; Models, Biological; Platelet Activating Factor; Shock | 1991 |
Platelet-activating factor and cytokine interactions in shock.
Topics: Animals; Biological Factors; Cytokines; Humans; Platelet Activating Factor; Shock | 1989 |
Induction of tissue injury and altered cardiovascular performance by platelet-activating factor: relevance to multiple systems organ failure.
Topics: Animals; Capillary Permeability; Cardiovascular System; Heart; Hemodynamics; Humans; Multiple Organ Failure; Platelet Activating Factor; Shock; Vascular Resistance | 1989 |
[Platelet-activating factor].
Topics: Animals; Platelet Activating Factor; Shock | 1989 |
Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
Topics: Anaphylaxis; Animals; Bronchial Spasm; Diterpenes; Ginkgolides; Graft Rejection; Hemodynamics; Humans; Immune System Diseases; In Vitro Techniques; Kidney Diseases; Lactones; Leukocytes; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Shock; Thrombosis | 1986 |
Platelet-activating factor: a potential mediator of shock.
Topics: Animals; Disease Models, Animal; Immunoglobulin G; Platelet Activating Factor; Shock; Shock, Septic | 1987 |
Prostaglandins, leukotrienes, and platelet-activating factor in shock.
Topics: Animals; Fatty Acids, Unsaturated; Humans; Leukotriene B4; Platelet Activating Factor; Prostaglandins; Shock; SRS-A; Thromboxane A2 | 1987 |
Platelet-activating factor and shock.
Topics: Animals; Platelet Activating Factor; Shock | 1988 |
Thyrotropin-releasing hormone (TRH) and circulatory shock.
Topics: Anaphylaxis; Animals; Brain; Cardiovascular System; Cats; Endorphins; Guinea Pigs; Hypotension; Lipoxygenase Inhibitors; Platelet Activating Factor; Rats; Shock; Shock, Hemorrhagic; Shock, Septic; SRS-A; Thyrotropin-Releasing Hormone | 1986 |
[Shock mediators and their antagonists as future therapeutic perspectives].
Topics: Arachidonic Acid; Arachidonic Acids; Calcium; Endothelium, Vascular; Free Radicals; Humans; Interleukin-1; Oxygen Consumption; Peptide Hydrolases; Platelet Activating Factor; Shock; Tumor Necrosis Factor-alpha | 1988 |
41 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Shock
Article | Year |
---|---|
Pyruvate in oral rehydration salt improves hemodynamics, vasopermeability and survival after burns in dogs.
Topics: Animals; Bicarbonates; Burns; Capillary Permeability; Disease Models, Animal; Dogs; Fluid Therapy; Fluorescein-5-isothiocyanate; Glucose; Hemodynamics; Lactic Acid; Platelet Activating Factor; Potassium Chloride; Pyruvic Acid; Random Allocation; Shock; Sodium Chloride; Vascular Endothelial Growth Factor A | 2016 |
Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor.
Topics: Adenoviridae; Animals; Cytokines; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Lipids; Mononuclear Phagocyte System; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Shock; Signal Transduction; Thrombocytopenia | 2010 |
2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52)--a novel type of 5-lipoxygenase inhibitor with favourable molecular pharmacology and efficacy in vivo.
Topics: Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Caprylates; Carrageenan; Leukotriene B4; Lipoxygenase Inhibitors; Male; Mice; Neutrophils; Nuclear Envelope; Platelet Activating Factor; Pleurisy; Protein Transport; Pyrimidines; Rats; Rats, Wistar; Shock | 2011 |
Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Dogs; Electrocardiography; Endotoxins; Heart; Heart Rate; Myocardium; Oxygen Consumption; Platelet Activating Factor; Shock; Thromboxane B2 | 1983 |
Effect of NG-nitro-L-arginine on shock induced by endotoxin and by platelet activating factor in dogs.
Topics: Amino Acid Oxidoreductases; Analysis of Variance; Animals; Arginine; Dogs; Endothelium, Vascular; Endotoxins; Female; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Platelet Activating Factor; Shock; Shock, Septic | 1993 |
The platelet activating factor as a pivotal mediator of shock after liver ischemia.
Topics: Animals; Hypotension; Ischemia; Isoquinolines; Liver; Liver Failure; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Shock; Tetrahydroisoquinolines | 1995 |
Endogenous bacterial toxins are required for the injurious action of platelet-activating factor in rats.
Topics: Analysis of Variance; Animals; Bacterial Toxins; Drug Therapy, Combination; Endotoxins; Intestines; Male; Metronidazole; Necrosis; Neomycin; Platelet Activating Factor; Polymyxin B; Rats; Rats, Sprague-Dawley; Shock; Specific Pathogen-Free Organisms | 1995 |
Dual inhibition of platelet-activating factor and arachidonic acid metabolism by ajmaline and effect on carrageenan-induced rat paw oedema.
Topics: Ajmaline; Animals; Arachidonic Acid; Aspirin; Blood Platelets; Carbon Radioisotopes; Carrageenan; Edema; Humans; Indomethacin; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rabbits; Rats; Shock | 1993 |
Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene.
Topics: Anaphylaxis; Animals; Arachidonate 5-Lipoxygenase; Base Sequence; Female; Inflammation; Leukotrienes; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Molecular Sequence Data; Platelet Activating Factor; Shock; Shock, Septic | 1994 |
Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
Topics: Animals; Blood Pressure; Male; Myocardial Depressant Factor; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Shock; Shock, Hemorrhagic | 1994 |
PAF-induced death in NMRI mice--a suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Azepines; Disease Models, Animal; Diterpenes; Eicosanoids; Female; Ginkgolides; Lactones; Masoprocol; Mice; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock; Species Specificity; Triazoles | 1993 |
Role of leukocyte beta 2-integrin in PAF-induced shock and intestinal injury.
Topics: Animals; Antibodies; Blood Pressure; CD18 Antigens; Intestine, Small; Leukocyte Count; Leukocytes; Macrophage-1 Antigen; Male; Necrosis; Peroxidase; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Shock | 1996 |
Role of platelet-activating factor on cardiovascular dysfunction in postischemic shock in pigs.
Topics: Animals; Hemodynamics; Heparin; Ischemia; Leucine; Platelet Activating Factor; Shock; Swine | 1997 |
Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist.
Topics: Acute Disease; Animals; Blood Platelets; Dose-Response Relationship, Drug; Endotoxemia; Guinea Pigs; Humans; Imidazoles; Indoles; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rabbits; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock | 1997 |
P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality.
Topics: Animals; Anticoagulants; CD18 Antigens; Death; Hypotension; Intercellular Adhesion Molecule-1; Intestine, Small; Intestines; Leukocyte-Adhesion Deficiency Syndrome; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Necrosis; P-Selectin; Platelet Activating Factor; Polysaccharides; Rats; Shock; Species Specificity | 1997 |
Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock.
Topics: Animals; Fluid Therapy; Imidazoles; Leucine; Platelet Activating Factor; Resuscitation; Shock; Swine; Wounds and Injuries | 1998 |
Roles of nitric oxide synthases in platelet-activating factor-induced intestinal necrosis in rats.
Topics: Animals; Drug Evaluation, Preclinical; Enzyme Inhibitors; Intestine, Small; Male; Necrosis; Neutrophils; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Platelet Activating Factor; Prospective Studies; Random Allocation; Rats; Rats, Sprague-Dawley; Shock | 1999 |
Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock.
Topics: Animals; Blood Pressure; Endopeptidases; Esters; Gabexate; Guanidines; Humans; In Vitro Techniques; Inflammation; Intestinal Mucosa; Intestines; Leukocytes; Male; Multiple Organ Failure; N-Formylmethionine Leucyl-Phenylalanine; Neutropenia; Phospholipases A; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion; Serine Endopeptidases; Serine Proteinase Inhibitors; Shock; Splanchnic Circulation; Survival Rate | 2002 |
[Experimental study on platelet activating factor and systemic circulatory failure caused by ischemic liver].
Topics: Animals; Dogs; Ischemia; Liver; Platelet Activating Factor; Shock | 1992 |
Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonists.
Topics: Alkylation; Animals; Benzopyrans; Binding Sites; Blood Platelets; Bridged Bicyclo Compounds; Cell Membrane; Cytoplasmic Granules; Male; Mice; Molecular Structure; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridines; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock; Structure-Activity Relationship | 1992 |
Platelet-activating factor antagonists in experimental shock.
Topics: Acid-Base Equilibrium; Animals; Azepines; Blood Pressure; Electrocardiography; Endotoxins; Hyperkalemia; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Shock; Triazoles | 1992 |
Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock.
Topics: Anesthesia; Animals; Blood Pressure; Furans; Leukocyte Count; Macrophages; Male; Mice; Myocardial Depressant Factor; Phagocytosis; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Shock; Splanchnic Circulation; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1992 |
Platelet activating factor-induced shock and intestinal necrosis in the rat: role of endogenous platelet-activating factor and effect of saline infusion.
Topics: Animals; Azepines; Intestine, Large; Isotonic Solutions; Male; Necrosis; Peroxidase; Platelet Activating Factor; Rats; Rats, Inbred Strains; Shock; Sodium Chloride; Triazoles | 1991 |
Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimenta
Topics: Animals; Gas Chromatography-Mass Spectrometry; Hypotension; Lipopolysaccharides; Mice; Mice, Inbred ICR; Passive Cutaneous Anaphylaxis; Piperidines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pyridinium Compounds; Rats; Rats, Inbred F344; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock | 1991 |
Influence of some prostaglandins and prostaglandin analogues on PAF-induced shock in mice.
Topics: Animals; Cell Survival; Epoprostenol; Female; Iloprost; Mice; Platelet Activating Factor; Prostaglandins; Prostaglandins, Synthetic; Shock | 1990 |
Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Diterpenes; Dogs; Ginkgolides; Hemodynamics; Indomethacin; Lactones; Male; Mesenteric Arteries; Mesenteric Veins; Platelet Activating Factor; Prostaglandins; Reperfusion Injury; Shock; Thromboxane B2 | 1991 |
Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF).
Topics: Animals; Blood Pressure; Coronary Circulation; Diterpenes; Dogs; Ginkgolides; Hemodynamics; Hindlimb; Ischemia; Lactones; Platelet Activating Factor; Reperfusion; Shock | 1991 |
Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arterial Occlusive Diseases; Blood Pressure; Furans; Leukocyte Count; Leukopenia; Macrophages; Male; Phagocytosis; Platelet Activating Factor; Radioimmunoassay; Rats; Rats, Inbred Strains; Shock; Splanchnic Circulation; Thromboxane B2; Tumor Necrosis Factor-alpha | 1991 |
Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice.
Topics: Animals; Blood Pressure; Complement Activation; Complement C5; Dose-Response Relationship, Drug; Hematocrit; Intestinal Diseases; Leukocyte Count; Lipopolysaccharides; Mice; Mice, Mutant Strains; Necrosis; Neutrophils; Platelet Activating Factor; Shock; Tumor Necrosis Factor-alpha; Vinblastine | 1991 |
Effects of endothelin on the lethality induced by platelet-activating factor or endotoxin in the mouse.
Topics: Animals; Drug Synergism; Endothelins; Endotoxins; Escherichia coli; Male; Mice; Platelet Activating Factor; Shock | 1990 |
Capillary leakage complicated by compartment syndrome necessitating surgery.
Topics: Adult; Capillary Permeability; Compartment Syndromes; Diterpenes; Fluid Therapy; Ginkgolides; HIV Infections; Humans; Lactones; Male; Platelet Activating Factor; Rhabdomyolysis; Shock | 1990 |
[An experimental study on shock after temporary hepatic inflow occlusion and platelet activating factor (PAF)].
Topics: Animals; Aspartate Aminotransferases; Blood Pressure; Constriction; Liver; Male; Mitochondria; Platelet Activating Factor; Portasystemic Shunt, Surgical; Pyridinium Compounds; Rats; Rats, Inbred Strains; Shock | 1990 |
Effect of a platelet activating factor antagonist (CV6209) on shock caused by temporary hepatic inflow occlusion.
Topics: Analysis of Variance; Animals; Blood Pressure; Hypotension; Ligation; Liver; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Shock | 1990 |
Significance of lipid mediators in shock states.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Fatty Acids, Unsaturated; In Vitro Techniques; Leukotrienes; Lipid Metabolism; Platelet Activating Factor; Prostaglandins; Shock; Thromboxane B2 | 1989 |
Influence of inhibitors of the eicosanoid metabolism, and of eicosanoids- and PAF-acether antagonists on mortality and some biochemical parameters of three shock models.
Topics: Anaphylaxis; Animals; Aspirin; Diterpenes; Fatty Acids, Unsaturated; Female; Ginkgolides; Imidazoles; Ketotifen; Lactones; Masoprocol; Mice; Naphthalenes; Platelet Activating Factor; Rats; Rats, Inbred Strains; Shock; Shock, Septic | 1989 |
Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog.
Topics: Animals; Blood Pressure; Diterpenes; Dogs; Ginkgolides; Ischemia; Lactones; Platelet Activating Factor; Shock; Splanchnic Circulation | 1989 |
Detection of platelet-activating factor during traumatic shock.
Topics: Animals; Ascitic Fluid; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Shock | 1988 |
Role of adrenal steroids in the recovery from platelet activating factor challenge.
Topics: Adrenalectomy; Animals; Cortisone; Hematocrit; Hemodynamics; Hypotension; Male; Mice; Platelet Activating Factor; Rats; Rats, Inbred Strains; Shock | 1987 |
PAF-acether and leukotriene participation in acute circulatory shock.
Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Dogs; Guinea Pigs; Hemodynamics; Male; Mice; Microcirculation; Platelet Activating Factor; Regional Blood Flow; Shock; Shock, Hemorrhagic; Shock, Septic; SRS-A | 1986 |
Evidence of a role for PAF-acether in the pathophysiology of the shock state.
Topics: Animals; Blood Pressure; Diterpenes; Ginkgolides; Hemodynamics; Humans; Immunoglobulin G; Lactones; Mice; Plant Extracts; Platelet Activating Factor; Rats; Shock | 1986 |
Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
Topics: Animals; Blood Pressure; Decerebrate State; Male; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Inbred Strains; Shock; Shock, Hemorrhagic; Shock, Septic; Thiazoles | 1986 |